6
M.N. Soltani Rad, F. Soleimani / Tetrahedron xxx (2016) 1e7
4.2. General procedure for one-pot N-alkylation of nucleo-
bases via alcohols using TPP/I2
cmꢂ1: 3281, 3050, 2937, 1728, 1712, 1570, 1452; MS [m/z (%)]: 196
(9.8); Anal. Calcd for C9H12N2O3: C, 55.09; H, 6.16; N, 14.28. Found:
C, 55.17; H, 6.28; N, 14.19.
In a double-necked round bottom flask (100 mL) equipped with
a condenser was added a mixture, consisting of alcohol (1 mmol),
TPP (1 mmol), I2 (1 mmol) Et3N (1 mmol), K2CO3 (1 mmol), and the
desire nucleobase (1 mmol) in anhydrous DMF (5 mL).33 The mix-
ture was heated at reflux. Heating was continued until TLC in-
dicated no further improvement in the conversion (Table 5). The
solvent was evaporated under vacuum and the remaining foam was
dissolved in CHCl3 (100 mL) and subsequently washed with water
(2ꢁ100 mL). The organic layer was dried (Na2SO4) and evaporated.
The crude product was purified by short column chromatography
on silica gel eluting with proper solvents.
4.3.5. 1-(3-Phenylpropyl)pyrimidine-2,4(1H,3H)-dione (2f). Column
chromatography purification on silica gel with n-hexane/EtOAc
(2:1) afforded white solid (1.70 g, 74%); mp¼107e108 ꢀC; Rf (EtOAc)
0.42; 1H NMR (DMSO-d6, 250 MHz) dppm: 1.88e1.91 (m, 2H,
PhCH2CH2), 2.55 (t, 2H, J¼7.0 Hz, PhCH2), 3.67 (t, 2H, J¼7.0 Hz,
NCH2), 5.52 (d, 1H, J¼7.3 Hz, C(5)eH, uracil), 7.25 (d, 1H, J¼7.3 Hz,
C(6)eH, uracil), 7.59e7.65 (m, 5H, aryl), 11.23 (s, 1H, NH, ex-
changeable with D2O); 13C NMR (DMSO-d6, 62.5 MHz) dppm: 27.3,
33.7, 47.3, 103.1, 126.9, 128.2, 128.9, 137.9, 142.3, 151.8, 164.0; IR
(KBR)
n
cmꢂ1: 3300, 3080, 2961, 1425, 1710, 1542, 1449; MS [m/z
(%)]: 230 (12.5); Anal. Calcd for C13H14N2O2: C, 67.81; H, 6.13; N,
12.17. Found: C, 67.94; H, 6.02; N, 12.25.
4.3. Data for new compounds
4.3.1. 1,3-Dimethyl-7-(2-(4-methylthiazol-5-yl)ethyl)-1H-purine-
2,6(3H,7H)-dione (1h). Column chromatography purification on
silica gel with n-hexane/EtOAc (1:1) afforded creamy solid (2.44 g,
80%); mp¼185e186 ꢀC; Rf (EtOAc) 0.31; 1H NMR (DMSO-d6,
250 MHz) dppm: 2.28 (s, 3H, C]CCH3), 3.29 (s, 3H, N(3)eCH3), 3.33
(t, 2H, J¼7.0 Hz, C]CCH2), 3.46 (s, 3H, N(1)eCH3), 4.42 (t, 2H,
J¼7.0 Hz, NCH2), 7.96 (s, 1H, C(8)eH, theophylline), 8.87 (s, 1H,
C(2)eH, thiazole); 13C NMR (DMSO-d6, 62.5 MHz) dppm: 16.5, 27.4,
30.8, 33.6, 52.7, 108.4, 130.5, 145.1, 149.7, 151.1, 152.0, 152.9, 155.7; IR
4.3.6. 1-(2-(2-Methyl-4-nitro-1H-imidazol-1-yl) ethyl)-1H-benzo [d]
imidazole (3b). Column chromatography purification on silica gel
with EtOAc afforded pale yellow solid (2.25 g, 83%); mp
223e224 ꢀC; Rf (MeOH/EtOAc, 1:10) 0.30; 1H NMR (DMSO-d6,
250 MHz) dppm: 1.82 (s, 3H, CH3), 4.43 (t, 2H, J¼6.2 Hz, NCH2), 4.68
(t, 2H, J¼6.2 Hz, NCH2), 7.17e7.20 (m, 2H, aryl), 7.49 (d, 1H, J¼7.5 Hz,
aryl), 7.65 (d,1H, J¼7.5 Hz, aryl), 8.01 (s,1H, C(5)eH, imidazole), 8.16
(s, 1H, C(2)eH, benzimidazole); 13C NMR (DMSO-d6, 62.5 MHz)
dppm: 12.0, 44.0, 46.1, 109.8, 119.4, 121.9, 122.1, 122.5, 133.5, 143.1,
(KBr)
n
cmꢂ1: 3070, 2965, 1715, 1703, 1571, 1450; MS [m/z (%)]: 305
143.8, 145.0, 145.4; IR (KBr) n
cmꢂ1: 3210, 3100, 2980, 2895, 1532,
(14.2); Anal. Calcd for C13H15N5O2S: C, 51.13; H, 4.95; N, 22.94; S,
10.50. Found: C, 51.21; H, 5.07; N, 22.85; S, 10.56.
1472, 1357; MS [m/z (%)]: 271 (33.2); Anal. Calcd for C13H13N5O2: C,
57.56; H, 4.83; N, 25.82. Found: C, 57.51; H, 4.89; N, 25.83.
4.3.2. 7-(4-(1,3-Dioxoisoindolin-2-yl)butyl)-1,3-dimethyl-1H-pu-
rine-2,6(3H,7H)-dione (1i). Column chromatography purification
on silica gel with n-hexane/EtOAc (1:1) afforded white solid
(3.20 g, 84%); mp¼234e235 ꢀC; Rf (EtOAc) 0.43; 1H NMR (DMSO-
d6, 250 MHz) dppm: 1.47e1.53 (m, 2H, CH2), 1.77e1.82 (m, 2H, CH2),
3.18 (s, 3H, N(3)eCH3), 3.36 (s, 3H, N(1)eCH3), 3.51 (t, 2H, J¼6.6 Hz,
NCH2), 4.19 (t, 2H, J¼6.6 Hz, NCH2), 7.65e7.72 (m, 4H, aryl), 8.03 (s,
4.3.7. 7-(2-(1H-Benzo[d]imidazole-1-yl)ethyl)-1,3-dimethyl-1H-pu-
rine-2,6(3H,7H)-dione (3c). Column chromatography purification
on silica gel with MeOH/EtOAc (1:14) afforded pale yellow solid
(2.78 g, 86%); mp¼244e245 ꢀC; Rf (MeOH/EtOAc,1:5) 0.24; 1H NMR
(CDCl3, 250 MHz) dppm: 3.44 (s, 3H, N(3)eCH3), 3.54 (s, 3H, N(1)e
CH3), 4.67e4.71 (m, 4H, NCH2CH2N), 6.98 (s, 1H, C(2)eH, benz-
imidazole), 7.28e7.42 (m, 4H, aryl), 7.59 (s, 1H, C(8)eH, theophyl-
line); 13C NMR (CDCl3, 62.5 MHz) dppm: 29.4, 31.4, 50.3, 56.2, 105.9,
115.1, 117.1, 124.3, 126.2, 133.0, 136.1, 142.6, 146.1, 149.6, 152.0, 155.7;
1H, C(8)eH, theophylline); 13C NMR (DMSO-d6, 62.5 MHz) dppm
:
27.1, 29.4, 30.4, 32.2, 41.1, 49.5, 107.3, 127.1, 132.0, 132.7, 145.6,
150.5, 151.4, 154.9, 170.1; IR (KBr)
cmꢂ1: 3100, 2947, 1718, 1706,
1590, 1532, 1448; MS [m/z (%)]: 381 (18.7); Anal. Calcd for
19H19N5O4: C, 59.84; H, 5.02; N, 18.36. Found: C, 59.93; H, 5.16; N,
n
IR (KBr) n
cmꢂ1: 3094, 2952, 1718, 1702, 1479; MS [m/z (%)]: 324
(20.4); Anal. Calcd for C16H16N6O2: C, 59.25; H, 4.97; N, 25.91.
Found: C, 59.37; H, 5.06; N, 25.98.
C
18.25.
Acknowledgements
4.3.3. 2-(6-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)hexyl)isoi-
ndoline-1,3-dione (2d). Column chromatography purification on
silica gel with n-hexane/EtOAc (1:2) afforded white solid (2.59 g,
76%); mp¼150e151 ꢀC; Rf (EtOAc) 0.59; 1H NMR (DMSO-d6,
250 MHz) dppm: 1.23e1.36 (m, 4H, 2CH2), 1.63e1.66 (m, 4H, 2CH2),
3.60e3.74 (m, 4H, 2NCH2), 5.59 (d, 1H, J¼7.8 Hz, C(5)eH, uracil),
7.70 (d, 1H, J¼7.8 Hz, C(6)eH, uracil), 7.88e7.96 (m, 4H, aryl), 11.29
(s, 1H, NH, exchangeable with D2O); 13C NMR (DMSO-d6,
62.5 MHz) dppm: 25.9, 26.3, 27.3, 28.0, 41.2, 47.9, 101.9, 127.2, 132.1,
We wish to thank the Shiraz University of Technology Research
Councils for partial support of this work.
Supplementary data
Supplementary data including characterization data and copies
of NMR spectra (1H and 13C NMR) for all compounds associated
with this article can be found in the online version, at http://
and InChiKeys of the most important compounds described in this
article.
133.0, 141.6, 151.4, 163.4, 169.5; IR (KBR)
1730, 1710, 1590, 1472; MS [m/z (%)]: 341 (18.9); Anal. Calcd for
18H19N3O4: C, 63.33; H, 5.61; N, 12.31. Found: C, 63.40; H, 5.73; N,
n
cmꢂ1: 3240, 3035, 2968,
C
12.19.
References and notes
4.3.4. 1-((Tetrahydrofuran-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione
(2e). Column chromatography purification on silica gel with n-
hexane/EtOAc (1:1) afforded yellow oil (1.37 g, 70%); Rf (EtOAc)
0.48; 1H NMR (DMSO-d6, 250 MHz) dppm: 1.85e1.93 (m, 4H,
CH2CH2), 3.65e3.82 (m, 5H, NCH2CH, OCH2), 5.70 (d, 1H, J¼7.9 Hz,
C(5)eH, uracil), 7.63 (d, 1H, J¼7.9 Hz, C(6)eH, uracil), 12.10 (s, 1H,
ꢁ
ꢂꢁ
ꢁ
ꢂꢂ
ꢁ
NH, exchangeable with D2O); 13C NMR (DMSO-d6, 62.5 MHz) dppm
:
26.3, 34.6, 52.7, 71.1, 77.9, 103.6, 142.7, 152.5, 164.3; IR (liquid film)
n